期刊文献+

表观扩散系数与表观扩散系数比值对前列腺癌的诊断价值及与病理分级的相关性 被引量:8

Apparent Diffusion Coefficient and Apparent Diffusion Coefficient Ratio on the Diagnosis of Prostate Cancer and Their Relationship with Gleason Scores
下载PDF
导出
摘要 目的探讨MR表观扩散系数(ADC)值与ADC比值在前列腺癌中诊断的价值,及其与病理Gleason评分的相关性,评估肿瘤的侵袭性。资料与方法回顾性分析疑诊前列腺癌而行前列腺磁共振-经直肠超声融合成像引导穿刺活检的116例患者,术前行前列腺MRI检查,常规扫描T1WI、T2WI及扩散加权成像序列,以b=0、1000 s/mm^2建立ADC图,测量病灶ADC值、对称位置相对正常前列腺ADC值,并计算两者的比值,以穿刺活检病理为对照,评估前列腺MRI的ADC值、ADC比值对前列腺癌的诊断价值,并评估其与病理Gleason评分的相关性。结果 116例患者穿刺活检前列腺癌检出率为56.0%(65/116)。ADC值及ADC比值诊断前列腺癌的ROC曲线下面积分别为0.842、0.879。ADC值及ADC比值在Gleason 6分组与Gleason 7分组间比较,差异有统计学意义(P<0.05),其余组间差异无统计学意义(P>0.05)。结论 ADC值及ADC比值对前列腺癌有较高的诊断价值,两者数值高低可初步判定低危与高危前列腺癌。 Purpose To investigate the value of apparent diffusion coefficient(ADC) and ADC ratio on the diagnosis of prostate carcinoma and their relationship with Gleason scores and evaluate the aggressiveness of prostate cancer. Materials and Methods For 116 patients confirmed prostate cancer by biopsy were included in this study. Each patient had suspicious lesions on T1WI, T2WI, DWI or ADC map(b=0, 1000 s/mm^2). ADC and ADC ratio of suspicious lesions and symmetrical normal tissue were obtained. All patients underwent magnetic resonance imaging-transrectal ultrasound guided biopsy and 12-core systematic biopsy. The diagnostic value of MRI and their relationship with Gleason scores was analysis. Results Among 116 patients, the detective rate of prostate cancer was 56.0%(65/116). The area under roc curve of ADC and ADC ratio were 0.842 and 0.879, respectively. There was statistically significance in ADC value and ADC ratio between Gleason scores of 6 and 7(P〈0.05); and no statistically significance among the other groups(P〉0.05). Conclusion The ADC value and ADC ratio are remarkably lower in prostate cancer than those in other diseases. Decrease of ADC value and ADC ratio may represent high risk of poorly differentiated cancer.
出处 《中国医学影像学杂志》 CSCD 北大核心 2016年第8期608-611,共4页 Chinese Journal of Medical Imaging
关键词 前列腺肿瘤 磁共振成像 表观扩散系数 病理学 临床 Prostatic neoplasms Magnetic resonance imaging Apparent diffusion coefficient Pathology clinical
  • 相关文献

参考文献11

  • 1Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012.CA Cancer J Clin,2015,65(2):87-108.
  • 2韩苏军,张思维,陈万青,李长岭.中国前列腺癌发病现状和流行趋势分析[J].临床肿瘤学杂志,2013,18(4):330-334. 被引量:765
  • 3De Cobelli F,Ravelli S,Esposito A,et al.Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading:comparison with prostate biopsy and radical prostatectomy specimen.Am J Roentgenol,2015,204(3):550-557.
  • 4孙丽娜,李前程,程凯亮,张孟超,刘云霞.磁共振扩散加权成像鉴别诊断前列腺癌与良性前列腺增生的Meta分析[J].中国医学影像学杂志,2013,21(6):464-467. 被引量:18
  • 5Le JD,Tan N,Shkolyar E,et al.Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging:correlation with whole-mount histopathology.Eur Urol,2015,67(3):569-576.
  • 6Renard-Penna R,Mozer P,Cornud F,et al.Prostate imaging reporting and data system and likert scoring system:multiparametric MR imaging validation study to screen patients for initial biopsy.Radiology,2015,275(2):458-468.
  • 7Sankineni S,Osman M,Choyke PL,et al.Functional MRI in prostate cancer detection.Biomed Res Int,2014:590638.
  • 8Kim JY,Kim SH,Kim YH,et al.Low-risk prostate cancer:the accuracy of multiparametric MR imaging for detection.Radiology,2014,271(2):435-444.
  • 9Dickinson L,Ahmed HU,Allen C,et al.Magnetic resonance imaging for the detection,localisation,and characterisation of prostate cancer:recommendations from a European consensus meeting.Eur Urol,2011,59(4):477-494.
  • 10Thompson JE,Moses D,Shnier R,et al.Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection:a prospective study.J Urol,2014,192(1):67-74.

二级参考文献22

  • 1郭雪梅,王霄英,李飞宇,许玉峰,肖江喜,蒋学祥.前列腺磁共振扩散加权成像的初步研究[J].中国医学影像技术,2005,21(12):1858-1861. 被引量:14
  • 2史浩,丁红宇.弥散加权成像在前列腺癌诊断与鉴别诊断中的应用价值[J].中华男科学杂志,2007,13(7):605-609. 被引量:13
  • 3赫杰,赵平,陈万青.2011中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:2-5,26 -37,74 -75.
  • 4Segi M. Cancer mortality for selected sites in 24 countries(1950-57 ) [ M ]. Japan : Department of Public Health,Tohoku Univer-sity of Medicine, 1960.
  • 5FerlayJ, Shin HR, Bray F, et al. Estimates of worldwide burdenof cancer in 2008 : GLOBOCAN 2008 [ J]. Int J Cancer, 2010,127(12) : 2893 -2917.
  • 6Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin’2011,61(2) :69 -90.
  • 7Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 [ J].CA Cancer J Clin,2012,62( 1) :10 - 29.
  • 8Oto A, Kayhan A, Jiang Y, et al. Prostate cancer: differentiationof central gland cancer from benign prostatic hyperplasia byusing diffusion-weighted and dynamic contrast-enhanced MRimaging. Radiology, 2010,257(3): 715-723.
  • 9Issa B. In vivo measurement of the apparent diffusioncoefficient in normal and malignant prostatic tissues usingecho-planar imaging. J Magn Reson Imaging, 2002,16(2):196-200.
  • 10Li C, Chen M, Li S, et al. Diffusion tensor imaging of prostateat 3.0 Tesla. Acta Radiol, 2011, 52(7): 813-817.

共引文献790

同被引文献66

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部